Şenol BEKMEZ, Mehmet AYVAZ, Altug YUCEKUL, AHMET MAZHAR TOKGÖZOĞLU

Modular cementless prosthetic reconstruction after resection of lower extremity malignant tumor

Introduction: The aim of the study is to report the preliminary clinical and functional outcomes of amodular cementless tumor resection prosthesis system (Megasystem-C®, Waldemar Link GmbH&Co. KG,Hamburg, Germany) in patients undergoing limb salvage surgery with wide resection in a lower extremity primary or metastatic malignant bone tumor.Material and methods: Fifty-two consecutive patients (33 male and 19 female; mean age 37.1 years(range, 16 to 79) with primary or metastatic lower extremity malignant bone tumor who underwentwide resection and reconstruction with cementless Megasystem-C®system were included in the study.Patients were analyzed for age at diagnosis, gender, type and localization of the tumor, time of follow-up,patient and prosthesis survival, complications, oncological and functional outcomes.Results: Mean follow-up time was 43.2 months (range, 8 to 66). Cumulative patient survival rate was92.3 percent and cumulative prosthetic survival rate was 65.4 percent. 18 complications were recordedand 9 of them required revision (17.3 percent). Mean overall Musculoskeletal Tumor Society score scorewas 72.7 percent (range, 52 to 86). Subgroup analyzes demonstrated no difference in complication rates,overall patient or prosthetic survivals. Functional scores according to age, diagnosis and location of thereconstruction also were not signiŞcantly different.Conclusion: The preliminary short-term follow-up results revealed that, the new generation modularcementless endoprosthetic system offers promising clinical and functional outcomes with reasonablecomplication rates.Level of evidence: Level IV, Therapeutic study

___

1. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72:3227e3238.

2. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314:1600e1606.

3. Rougraff BT, Simon MA, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Jt Surg Am. 1994;76: 649e656.

4. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Jt Surg Am. 1986;68:1331e1337.

5. Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P. Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res. 2012 Jun;470(6):1735e1748.

6. Harris JE, Left AR, Gitelis S, Simon MA. Function after amputation, arthodesis or arthrplasty for tumors about the knee. J Bone Jt Surg. 1990;72A: 1477e1485.

7. Horowitz S, Glasser D, Lane J, Healey J. Prosthetic and extremity survivorship in limb salvage: how long do the reconstructions last? Clin Orthop Relat Res. 1993;293:280.

8. Khattak MJ, Umer M, Haroon-ur-Rasheed, Umar M. Autoclaved tumor bone for reconstruction: an alternative in developing countries. Clin Orthop Relat Res. 2006;447:138e144.

9. Farid Y, Lin PP, Lewis VO, Yasko AW. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res. 2006;442:223e229.

10. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Jt Surg Am. 1995;77A:1154e1165.

11. Roberts P, Chan D, Gimer RJ, Sneath RS, Scales JT. Prosthetic replacement of the distal femur for primary bone tumours. J Bone Jt Surg Br. 1991;73B:762.

12. Zeegen EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004;420:239e250.

13. Guo W, Ji T, Yang R, Tang X, Yang Y. Endoprosthetic replacement for primary tumours around the knee: experience from Peking University. J Bone Jt Surg Br. 2008;90:1084e1089.

14. Ward WG, Johnston KS, Dorey FJ, Eckardt JJ. Loosening of massive proximal femoral cemented endoprostheses. Radiographic evidence of loosening mechanism. J Arthroplasty. 1997;12:741e750.

15. Schwartz AJ, Kabo JM, Eilber FC, Eilber FR, Eckardt JJ. Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants. Clin Orthop Relat Res. 2010;468(8): 2198e2210.

16. Unwin PS, Cannon SR, Grimer RJ, Kemp HBS, Sneath RS, Walker PS. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Jt Surg Br. 1996;78:5e13.

17. Pala EMA, Mavrogenis AF, Angelini A, Henderson ER, Douglas Letson G, Ruggieri P. Cemented versus cementless endoprostheses for lower limb salvage surgery. J Buon. 2013;18(2):496e503.

18. Bruns J, Delling G, Gruber H, Lohmann CH, Habermann CR. Cementless fixation of megaprostheses using a conical fluted stem in the treatment of bone tumours. J Bone Jt Surg Br. 2007;89(8):1084e1087.

19. Abraham JA, Weaver MJ, Ready JE, Raskin KA, O'Brien E, Hornicek FJ. Shortterm outcomes of cementless modular endoprostheses in lower extremity reconstruction. Curr Orthop Pract. 2012;23:213e217.

20. Enneking WF, Dunham W. A system for the functional evaluation of Reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241e249.

21. Henderson ER, Groundland JS, Pala E, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Jt Surg Am. 2011;93:418e429.

22. Simon MA. Limb salvage for osteosarcoma in the 1980s. Clin Orthop Relat Res. 1991;270:264e270.

23. Horowitz SM, Lane JM, Otis JC, Healey JH. Prosthetic arthroplasty of the knee after resection of a sarcoma in the proximal end of the tibia. A report of sixteen cases. J Bone Jt Surg Am. 1991;73:286e293.

24. Pala E, Trovarelli G, Calabrio T, Angelini A, Abati CN, Ruggieri P. Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis. Clin Orthop Relat Res. 2015;473(3):891e899.

25. Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS. Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses. Clin Orthop Relat Res. 2006;450:52e59.

26. Regis D, Sandri A, Bonetti I, Braggion M, Bartolozzi P. Femoral revision with the Wagner tapered stem: a ten-to 15-year follow-up study. J Bone Jt J Br. 2011;93(10):1320e1326.

27. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247e1254.

28. Galasso O, Mariconda M, Brando A, Ianno B. Disassembly of a distal femur modular prosthesis after tumor resection. J Arthroplasty. 2010;25(2): 334.e5-9.

29. McDonald DJ, Capanna R, Gherlinzoni F, et al. Influence of chemotherapy on perioperative complications in limb salvage surgery for bone tumors. Cancer. 1990;65:1509e1516.

30. Mavrogenis AF, Pala E, Angelini A, et al. Infected prostheses after lowerextremity bone tumor resection: clinical outcomes of 100 patients. Surg Infect (Larchmt). 2015;16(3):267e275.

31. Mavrogenis AF, Mitsiokapa EA, Sakellariou VI, Tzanos G, Papagelopoulos PJ. Functional and radiographic outcome after tumor limb salvage surgery using STANMORE megaprostheses. J Buon. 2011 Apr-Jun;16(2):353e360.

32. Qadir I, Umer M, Baloch N. Functional outcome of limb salvage surgery with mega-endoprosthetic reconstruction for bone tumors. Arch Orthop Trauma Surg. 2012;132(9):1227e1232.